BUY Info Edge (India) Limited — Sushil Kedia
bySushil KediaHorizon: NA (inferred 1 year)8 Nov 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Info Edge Q4 Review: Brokerages Stay Bullish, See AI Products Driving Growth; Check Target Price, Potential Upside
NewsNdtv-Profit·29 Oct · 1w ago
10 other SEBI-registered advisors have active long-term BUY calls on this stock, with 3 issued in the last 14 days
Advisor consensus · same horizon·29 Oct · 1w ago
Info Edge (India) Appoints Sanjeev Bikhchandani As Group CEO; Q2 Profit Rises 8% QoQ To Rs 480 Crore
NewsNdtv-Profit·28 Oct · 2w ago
Info Edge reported Q2FY27 billings growth of 12.8% YoY and operating PBT growth of 29.8%, with 99acres billings growth accelerating to 21.2%.
NSE · Press Release·28 Oct · 2w ago
Info Edge's subsidiary, Startup Investments (Holding) Ltd., will invest Rs 5 crore in Bizcrum Infotech (Bijnis) to acquire a 20.12% stake on a fully diluted basis.
BSE · Company Update·23 Oct · 2w ago
Info Edge NAUKRI Q2 FY27 Earnings Call Key Highlights
NewsGoogle News·30 Oct · 1w ago
Info Edge approved the divestment of its stakes in Medcords Healthcare and Unnati Online, and an investment of Rs 150 crore in its wholly-owned subsidiary, Redstart Labs.
NSE · Acquisition·28 Oct · 2w ago
Info Edge approved the divestment of its stakes in Medcords Healthcare Solutions and Unnati Online, and an investment of Rs 150 crore in its wholly-owned subsidiary, Redstart Labs.
BSE · Company Update·28 Oct · 2w ago
Info Edge (India) Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
NSE · Outcome of Board Meeting·28 Oct · 2w ago
Long-term trend bearish — 200-day average falling over the past quarter
Technicals · trend·6 Nov · 2d ago
Naukri brand parent Info Edge shares dip after ₹3 per share dividend move | Check payment, record date, history, yield
NewsLivemint·28 Oct · 2w ago
Hitesh Oberoi is transitioning from his role as MD & CEO after 27 years, with Sanjeev Bikhchandani assuming an expanded executive leadership role.
NSE · Press Release·28 Oct · 2w ago
Mr. Hitesh Oberoi is transitioning from his role as MD & CEO to a Non-Executive Non-Independent Director.
BSE · Company Update·28 Oct · 2w ago
Mr. Hitesh Oberoi is transitioning from his role as MD & CEO to a Non-Executive Non-Independent Director.
BSE · Company Update·28 Oct · 2w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Info Edge (India)
- BUY — Deven Mehata, IDBI Capital Markets and Securities6 Nov 2026 · ~2 weeks · target ₹1,315 · Active
- BUY — IDBI Capital5 Nov 2026 · ~2 weeks · target ₹1,315 · SL hit
- BUY — Akshay Bhagwat, JM Financial5 Nov 2026 · ~2 weeks · target ₹1,260 · Active
- BUY — Citigroup29 Oct 2026 · ~1 year · target ₹1,500 · Active
- BUY — Goldman Sachs29 Oct 2026 · ~1 year · target ₹1,430 · Active
More from Sushil Kedia
- BUY Neogen Chemicals8 Nov 2026 · ~2 weeks · target ₹2,765 · Active
- BUY Titan Company8 Nov 2026 · Next day · target ₹5,050 · Active
- BUY State Bank of India23 Sept 2026 · ~3 months · target ₹1,300 · Active
- BUY TATA CONSUMER PRODUCTS26 Aug 2026 · ~1 year · target ₹1,600 · Active
- BUY BSE12 Aug 2026 · ~1 year · target ₹5,200 · Active

